Cell Rep

1. CHUANG YM, Dong Y, Stone H, Abouneameh S, et al
   Anopheles gambiae lacking AgTRIO probe inefficiently on a mammalian host.
   Cell Rep. 2024;43:114600.
   

   >> Share

   
   

   
   J Infect Dis

2. NAMAZZI R, Mellencamp KA, Opoka RO, Datta D, et al
   Circulating immune complexes and G6PD deficiency predict readmissions for blackwater fever and severe anemia in children with severe malaria in Eastern Uganda.
   J Infect Dis. 2024 Aug 29:jiae431. doi: 10.1093.
   

   >> Share

   
   
3. LAURY JE, Mugittu K, Kajeguka DC, Kamugisha E, et al
   Efficacy and safety of artemether-lumefantrine against uncomplicated falciparum malaria infection in Tanzania, 2022, a single arm clinical trial.
   J Infect Dis. 2024 Aug 26:jiae425. doi: 10.1093.
   

   >> Share

   
   

   
   Malar J

4. MENDIS K, Fernando D, Ranaweera P, Gunasekera K, et al
   Preventing the re-establishment of malaria during the COVID-19 pandemic in Sri Lanka: implications for health security.
   Malar J. 2024;23:254.
   

   >> Share

   
   
5. DONOVAN L, Shafique M, Wharton-Smith A, Richardson S, et al
   Using the role model approach to optimise caregiver administration of sulfadoxine-pyrimethamine amodiaquine to children aged 3-59 months in Burkina Faso, Chad and Togo: findings from an evaluation.
   Malar J. 2024;23:255.
   

   >> Share

   
   
6. GRANGER DL, Ansong D, Agbenyega T, Liddle MS, et al
   Longitudinal associations of plasma amino acid levels with recovery from malarial coma.
   Malar J. 2024;23:253.
   

   >> Share

   
   
7. ANINAGYEI E, Agbenowoshie PS, Akpalu PM, Asiewe SB, et al
   ABO and Rhesus blood group variability and their associations with clinical malaria presentations.
   Malar J. 2024;23:257.
   

   >> Share

   
   
8. MWEBESA E, Awor S, Natuhamya C, Dricile R, et al
   Impact of mass media campaigns on knowledge of malaria prevention measures among pregnant mothers in Uganda: a propensity score-matched analysis.
   Malar J. 2024;23:256.
   

   >> Share

   
   
9. TAM LT, Thinkhamrop K, Suttiprapa S, Clements ACA, et al
   Bayesian spatio-temporal modelling of environmental, climatic, and socio-economic influences on malaria in Central Vietnam.
   Malar J. 2024;23:258.
   

   >> Share

   
   
10. ELHASSAN SIA
    Key contributors to malaria elimination in the People's Republic of China: a scoping review.
    Malar J. 2024;23:259.
    

    >> Share

    
    
11. MANDEFRO A, Kebede AM, Mekonen B, Katsvanga M, et al
    Novel Plasmodium falciparum histidine-rich protein 2/3 repeat type in Ethiopian malaria infection: does this affect performance of HRP2-based malaria RDT?
    Malar J. 2024;23:262.
    

    >> Share

    
    
12. KALBSKOPF V, Azelyte J, Palinauskas V, Hellgren O, et al
    Genomic variation in Plasmodium relictum (lineage SGS1) and its implications for avian malaria infection outcomes: insights from experimental infections and genome-wide analysis.
    Malar J. 2024;23:260.
    

    >> Share

    
    
13. OYEBOLA KM, Ligali FC, Owoloye AJ, Aina OO, et al
    Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers.
    Malar J. 2024;23:261.
    

    >> Share

    
    
14. LEQUECHANE JD, Craveiro I, Azevedo N, Abilio AP, et al
    Community participatory mapping of malaria mosquito breeding sites in Mozambique.
    Malar J. 2024;23:264.
    

    >> Share

    
    
15. KYOMUHANGI I, Yukich J, Saili K, Orange E, et al
    Evaluating trends in damage to attractive targeted sugar baits (ATSBs) deployed during the second year of a two-year Phase III trial in Western Zambia.
    Malar J. 2024;23:263.
    

    >> Share

    
    
16. KAYODE TA, Addo AK, Addison TK, Tweneboah A, et al
    Comparison of three rapid diagnostic tests for Plasmodium falciparum diagnosis in Ghana.
    Malar J. 2024;23:265.
    

    >> Share

    
    
17. WOLDESENBET D, Birhanie M, Abere A, Zeleke AJ, et al
    Therapeutic efficacy and safety of artemether-lumefantrine combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria at Teda Health Centre, Northwest Ethiopia, 2022/23.
    Malar J. 2024;23:266.
    

    >> Share

    
    

    
    Nat Immunol

18. WANG LT, Idris AH, Kisalu NK, Crompton PD, et al
    Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention.
    Nat Immunol. 2024;25:1530-1545.
    

    >> Share

    
    

    
    PLoS One

19. SYME T, N'dombidje B, Todjinou D, Ariori V, et al
    Laboratory evaluation of the regeneration time, efficacy and wash-resistance of PermaNet Dual (a deltamethrin-chlorfenapyr net) against susceptible and pyrethroid-resistant strains of Anopheles gambiae sensu lato.
    PLoS One. 2024;19:e0298513.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share